CEW Honors J&J, and Raises Money for Its Cancer and Careers Initiative
Johnson & Johnson Consumer Products was honored last December for its commitment to helping its employees overcome the challenges of combining work with cancer treatment. Carlotta Jacobson, president of Cosmetic Executive Women (CEW), presented the award to Colleen Goggins, worldwide chairman of J&J’s consumer and personal care group. “We’re proud to partner with CEW on a program that will make a difference in the lives of so many employees when they need it most,” Goggins said. The award was presented on December 12 at CEW’s annual luncheon in New York.Susan Arnot Heaney, director, corporate responsibility, Avon Products, spoke about the need for more companies to be involved in supporting Cancer and Careers, and CEW’s Managing Through Cancer Pioneer Program. “CEW is still the only voice helping to guide people through this most critical journey. There’s a drastic need for more support for people working through cancer, specifically with employment related issues. We need to do everything possible to expand this program,” she says.
In addition to the live auction held during the luncheon, CEW held an online auction. Together, the auctions raised more than $53,000. CEW member companies donated all the items that were auctioned during the luncheon and online.
Jacobson was proud of the CEW’s successful fundraising efforts over the past year. “This cause has truly been embraced by the beauty industry, and this is most evident at our holiday luncheon. This year was especially moving for us because of the success of our Fund-A-Need auction, where individuals gave directly to Cancer and Careers programs. We’ve always known that we had the support of corporations, but to have such support from individuals in the industry was just overwhelming,” Jacobson says. CEW’s Foundation is the charitable branch of CEW that supports Cancer and Careers, an independent initiative that provides vital insights, inspiration, and inspiration for working women during and after cancer treatment.